The Technical Analyst
iRhythm Technologies Inc [IRTC]
Exchange: NASDAQ Sector: Healthcare Industry: Medical Devices
iRhythm Technologies Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals
Current Signal: SELL (auto-tracking)
0.93% $114.68
America/New_York / 23 apr 2024 @ 10:30
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 3 552.49 mill |
| EPS: | -4.04 |
| P/E: | -28.38 |
| Earnings Date: | May 02, 2024 |
| SharesOutstanding: | 30.98 mill |
| Avg Daily Volume: | 0.448 mill |
| RATING 2024-04-22 |
|---|
| B- |
| Sell |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Sell | |
| Return On Equity: | Strong Sell | |
| Return On Asset: | Sell | |
| DE: | Buy | |
| P/E: | Strong Sell | |
| Price To Book: | Strong Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -28.38 | sector: PE -3.05 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| -0.13x |
| Company: PE -28.38 | industry: PE 222.16 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
$-74.77 (-165.20%) $-189.45 |
| Date: 2024-04-23 |
| Expected Trading Range (DAY) |
|---|
|
$ 110.45 - 119.41 ( +/- 3.89%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2024-02-28 | Murphy Patrick Michael | Buy | 0 | |
| 2024-02-27 | Murphy Patrick Michael | Buy | 0 | |
| 2024-03-04 | Day Mark J. | Sell | 3 248 | Common Stock |
| 2024-03-04 | Patterson Chad | Sell | 1 077 | Common Stock |
| 2024-03-04 | Blackford Quentin S. | Sell | 4 221 | Common Stock |
| INSIDER POWER |
|---|
| 52.39 |
| Last 96 transactions |
| Buy: 380 179 | Sell: 104 612 |
Forecast:
12:07 - $114.61
Live Trading Signals (every 1 min)
Forecast
1: 10:37 - $114.81
Forecast 2: 11:27 - $114.76
Forecast 3: 12:07 - $114.61
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $114.68 (0.93% ) |
| Volume | 0.0260 mill |
| Avg. Vol. | 0.448 mill |
| % of Avg. Vol | 5.82 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For IRTC
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % | Feb 8 - 15:34 | buy | $120.75 | N/A | Active |
|---|
IRTC
iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.
Latest Press Releases
2024-04-18 16:05:00 - Press Release
Irhythm Technologies To Report First Quarter 2024 Financial Results On May 2, 2024
San francisco, april 18, 2024 (globe newswire) -- irhythm technologies, inc. (nasdaq:irtc), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that it will release financial results for the first quarter 2024 after the close of trading on thursday, may 2, 2024. the company's management team will host a corresponding conference call beginning at 1:30 p.m. pt / 4:30 p.m. et.
2024-04-08 19:30:00 - Press Release
Investors Who Lost Money On Irhythm Technologies, Inc.(irtc) Should Contact Levi & Korsinsky About Pending Class Action - Irtc
New york, ny / accesswire / april 8, 2024 / if you suffered a loss on your irhythm technologies, inc. (nasdaq:irtc) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/irhythm-technologies-lawsuit-submission-form?prid=74832&wire=1 or contact joseph e. levi, esq.
2024-04-08 13:00:00 - Press Release
Levi & Korsinsky Notifies Irhythm Technologies, Inc. Investors Of A Class Action Lawsuit And Upcoming Deadline - Irtc
New york, ny / accesswire / april 8, 2024 / if you suffered a loss on your irhythm technologies, inc. (nasdaq:irtc) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/irhythm-technologies-lawsuit-submission-form?prid=74773&wire=1 or contact joseph e. levi, esq.
2024-04-08 11:45:00 - Press Release
Class Action Filed Against Irhythm Technologies, Inc. (irtc) Seeking Recovery For Investors - Contact Levi & Korsinsky
New york, ny / accesswire / april 8, 2024 / if you suffered a loss on your irhythm technologies, inc. (nasdaq:irtc) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/irhythm-technologies-lawsuit-submission-form?prid=74748&wire=1 or contact joseph e. levi, esq.
2024-04-08 10:22:00 - Press Release
Irtc Deadline Today: Rosen, A Ranked And Leading Firm, Encourages Irhythm Technologies, Inc. Investors To Secure Counsel Before Important April 8 Deadline In Securities Class Action – Irtc
New york--(business wire)--why: rosen law firm, a global investor rights law firm, reminds purchasers of common stock of irhythm technologies, inc. (nasdaq: irtc) between january 11, 2022 and may 30, 2023, both dates inclusive (the “class period”), of the important april 8, 2024 lead plaintiff deadline. so what: if you purchased irhythm common stock during the class period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangemen.
Latest News
2024-04-18 16:05:00 - GlobeNewsWire
iRhythm Technologies to Report First Quarter 2024 Financial Results on May 2, 2024
SAN FRANCISCO, April 18, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that it will release financial results for the first quarter 2024 after the close of trading on Thursday, May 2, 2024. The company's management team will host a corresponding conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET.
2024-04-08 05:11:04 - Zacks Investment Research
iRhythm Technologies (IRTC) Surges 4.2%: Is This an Indication of Further Gains?
iRhythm Technologies (IRTC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
2024-02-22 18:51:31 - Zacks Investment Research
IRhythm Technologies (IRTC) Reports Q4 Loss, Tops Revenue Estimates
IRhythm Technologies (IRTC) came out with a quarterly loss of $1.26 per share versus the Zacks Consensus Estimate of a loss of $0.60. This compares to loss of $0.67 per share a year ago.
2024-01-14 12:54:56 - InvestorPlace
7 Healthcare Stocks Taking Medicine to the Next Level
While the technology sector – especially regarding artificial intelligence – may have captured the spotlight, investors ought to consider adding healthcare stocks to their portfolio. If I had to boil it down to one phrase, it would be permanent relevance.
2023-12-26 16:30:00 - GlobeNewsWire
iRhythm Technologies to Present at the 42nd Annual J.P. Morgan Healthcare Conference
SAN FRANCISCO, Dec. 26, 2023 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today announced the company will be participating in the upcoming 42nd Annual J.P. Morgan Healthcare Conference.
2023-12-05 11:27:00 - Market Watch
Goldman Sachs money manager digs into three themes for long-term growth
Most exchange-traded funds are passively managed — they are designed to mirror the performance of stock indexes and typically have low management fees. They can work out very well for investors, which has been the case for funds that track the S&P 500.
2023-11-02 23:30:20 - Seeking Alpha
iRhythm Technologies, Inc. (IRTC) Q3 2023 Earnings Call Transcript
iRhythm Technologies, Inc. (NASDAQ:IRTC ) Q3 2023 Earnings Conference Call November 2, 2023 4:30 PM ET Company Participants Stephanie Zhadkevich - Director of Investor Relations Quentin Blackford - President & Chief Executive Officer Brice Bobzien - Chief Financial Officer Conference Call Participants Allen Gong - JPMorgan Malgorzata Kaczor - William Blair David Saxon - Needham Nathan Treybeck - Wells Fargo John Young - Canaccord David Rescott - Baird Suraj Kalia - Oppenheimer Operator Hello and welcome to the iRhythm Technologies Inc. Q3 2023 Earnings Conference Call. My name is Alex, I'll be coordinating the call today.
2023-10-27 11:18:52 - Zacks Investment Research
Down -23.87% in 4 Weeks, Here's Why iRhythm Technologies (IRTC) Looks Ripe for a Turnaround
The heavy selling pressure might have exhausted for iRhythm Technologies (IRTC) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
2023-10-19 16:05:00 - GlobeNewsWire
iRhythm Technologies to Report Third Quarter 2023 Financial Results on November 2, 2023
SAN FRANCISCO, Oct. 19, 2023 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that it will release financial results for the third quarter 2023 after the close of trading on Thursday, November 2, 2023. The company's management team will host a corresponding conference call beginning at 1:30 p.m.
2023-09-28 09:46:19 - Zacks Investment Research
iRhythm Technologies (IRTC) Moves 7.4% Higher: Will This Strength Last?
iRhythm Technologies (IRTC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.